{"transactions":[{"id":1580193,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-12T22:37:25.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":65000,"derivative":{"exercise_price":44.37,"expiration_date":"2034-03-10","underlying":"Common Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000950170-24-030236","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000095017024030236/ownership.xml","form_type":"4"}},{"id":1953568,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-14T20:27:38.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":75000,"derivative":{"exercise_price":34.18,"expiration_date":"2033-03-09","underlying":"Common Shares","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-23-018470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919123018470/doc4.xml","form_type":"4"}},{"id":2183641,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-16T21:36:13.000Z","date":"2022-08-12","kind":"exercise","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.75,"expiration_date":"2028-03-11","underlying":"Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-22-046017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122046017/doc4.xml","form_type":"4"}},{"id":2183640,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-16T21:36:13.000Z","date":"2022-08-12","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.1,"expiration_date":"2027-10-22","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-046017","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122046017/doc4.xml","form_type":"4"}},{"id":2183639,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-08-16T21:36:13.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":21875,"price":38.68,"value":846125.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.6084 to $38.7884, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-22-046017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122046017/doc4.xml","form_type":"4"}},{"id":2183638,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-08-16T21:36:13.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":35868,"price":38.08,"value":1365853.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $37.5101 to $38.5029, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":31875,"source":{"system":"sec-edgar","filing":"0001209191-22-046017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122046017/doc4.xml","form_type":"4"}},{"id":2183637,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-08-16T21:36:13.000Z","date":"2022-08-12","kind":"tax_withholding","acquired":false,"shares":7257,"price":38.02,"value":275911.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the closing price of the Company's common shares on August 11, 2022 for purposes of net settlement calculations."}],"balance_after":67743,"source":{"system":"sec-edgar","filing":"0001209191-22-046017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122046017/doc4.xml","form_type":"4"}},{"id":2183636,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-08-16T21:36:13.000Z","date":"2022-08-12","kind":"exercise","acquired":true,"shares":45000,"price":4.75,"value":213750.0,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001209191-22-046017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122046017/doc4.xml","form_type":"4"}},{"id":2183635,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-08-16T21:36:13.000Z","date":"2022-08-12","kind":"exercise","acquired":true,"shares":20000,"price":3.1,"value":62000.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-22-046017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122046017/doc4.xml","form_type":"4"}},{"id":2334877,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T20:10:02.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2023 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":65000,"derivative":{"exercise_price":30.01,"expiration_date":"2032-03-09","underlying":"Common Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-22-018440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122018440/doc4.xml","form_type":"4"}},{"id":2343723,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-07","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vesting 25% on February 9, 2017 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":0,"derivative":{"exercise_price":6.76,"expiration_date":"2026-02-07","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343722,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-07","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vesting 25% on January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":0,"derivative":{"exercise_price":8.4,"expiration_date":"2027-03-12","underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343721,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vesting 25% on January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":0,"derivative":{"exercise_price":8.4,"expiration_date":"2027-03-12","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343720,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":31048,"price":30.54,"value":948205.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.5161 to $30.6208, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343719,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":1805,"price":30.62,"value":55269.1,"ownership":{"direct":true},"balance_after":41048,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343718,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-07","kind":"tax_withholding","acquired":false,"shares":8952,"price":30.23,"value":270618.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the closing price of the Company's common shares on March 4, 2022 which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":42853,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343717,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-07","kind":"exercise","acquired":true,"shares":40000,"price":6.76,"value":270400.0,"ownership":{"direct":true},"balance_after":51805,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343716,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-07","kind":"tax_withholding","acquired":false,"shares":695,"price":30.23,"value":21009.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the closing price of the Company's common shares on March 4, 2022 which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":11805,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343715,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-07","kind":"exercise","acquired":true,"shares":2500,"price":8.4,"value":21000.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343714,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":18315,"price":30.79,"value":563918.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $30.21 to $31.0296, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343713,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-04","kind":"tax_withholding","acquired":false,"shares":6685,"price":31.42,"value":210042.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the closing price of the Company's common shares on March 3, 2022 which was converted to a Canadian dollar amount for purposes of net settlement calculations."}],"balance_after":28315,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2343712,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2022-03-09T00:32:07.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":25000,"price":8.4,"value":210000.0,"ownership":{"direct":true},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-22-017316","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919122017316/doc4.xml","form_type":"4"}},{"id":2788739,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T20:35:43.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2022 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":65000,"derivative":{"exercise_price":20.55,"expiration_date":"2031-03-11","underlying":"Common Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-21-020473","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919121020473/doc4.xml","form_type":"4"}},{"id":3210391,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-13T21:12:27.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2021 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":65000,"derivative":{"exercise_price":11.58,"expiration_date":"2030-03-11","underlying":"Common Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-20-018969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919120018969/doc4.xml","form_type":"4"}},{"id":3410486,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T22:28:15.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting over 36 months, in equal amounts, on the last day of each month."}],"balance_after":40000,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-050129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000120919119050129/doc4.xml","form_type":"4"}},{"id":3997566,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-13T21:44:18.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2019, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":45000,"derivative":{"exercise_price":4.75,"expiration_date":"2028-03-11","underlying":"Common Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001171843-18-001917","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184318001917/form4.xml","form_type":"4"}},{"id":4181059,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-24T22:44:16.000Z","date":"2017-10-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on October 23, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":20000,"derivative":{"exercise_price":3.1,"expiration_date":"2027-10-22","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001171843-17-006254","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184317006254/formfour.xml","form_type":"4"}},{"id":4230243,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Drug Discovery"}}],"security":"Common Shares","published_at":"2017-08-17T21:33:58.000Z","date":"2017-08-15","kind":"purchase","acquired":true,"shares":10000,"price":2.4824,"value":24824.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001171843-17-005162","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184317005162/formfour.xml","form_type":"4"}},{"id":4385778,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":93146,"kind":"person","name":"EMPFIELD JAMES R.","position":1,"cik":"0001665430","reported_name":"EMPFIELD JAMES R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Drug Discovery"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-14T20:28:57.000Z","date":"2017-03-13","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":27500,"derivative":{"exercise_price":8.4,"expiration_date":"2027-03-12","underlying":"Common Shares","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001171843-17-001511","document":"f4_empfield031417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582313/000117184317001511/f4_empfield031417.xml","form_type":"4"}}]}